Kanvas Biosciences

United States · Biotech · Healthtech · AI · Enterprise software

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$48MAlumni Ventures — Role not disclosedATHOS KG — Role not disclosedBoutique Venture Partners — Role not disclosedCornell University — Role not disclosedDCVC — Role not disclosedFemHealth Ventures — Role not disclosedGaingels — Role not disclosedGates Foundation — Role not disclosedGermin8 — Role not disclosedKicker Ventures — Role not disclosedKi Tua Fund — Role not disclosedLions Capital LLC — Role not disclosedMana Ventures — Role not disclosedPangaea Ventures — Role not disclosedRed Bear Ventures — Role not disclosedRIT Venture Fund — Role not disclosedTriple Impact Capital — Role not disclosedUncommon Denominator — Role not disclosed
Sourceskanvasbio.com ↗